Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 24 (4) , 430-441
Abstract
To explore the relationship between lipometabolism-related microRNAs (miRNAs) in peripheral blood mononuclear cells (PBMCs) and the presence of coronary artery disease (CAD). In the present study, 161 stable CAD patients and 149 health controls were enrolled. The expression levels of seven miRNAs (miR-21, miR-24, miR-29a, miR-33a, miR-34a, miR-103a, and miR-122) in PBMCs were qualified by quantitative real-time polymerase chain reaction (qRT-PCR). The miRNA markers that showed significant difference between the two groups were used for further analysis. The risk of miRNA contributing to the presence of CAD was estimated by univariate and multivariate logistic regression models. The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. The expression levels of miR-24, miR-33a, miR-103a, and miR-122 in PBMCs were significantly increased in CAD patients compared with controls and were significantly correlated with blood lipids in both CAD patients and controls. The increased levels of miR-24 (adjusted OR=1.32, 95% CI 1.07-1.62, P=0.009), miR-33a (adjusted OR=1.57, 95% CI 1.35-1.81, P<0.001), miR-103a (adjusted OR=1.01, 95% CI 1.01-1.02, P<0.001), and miR-122 (adjusted OR=1.03, 95% CI 1.01-1.04, P<0.001) were associated with risk of CAD. We identified a miRNA panel (miR-24, miR-33, miR-103a, and miR-122) that provided a high diagnostic accuracy of CAD (AUC=0.911, 95% CI 0.880-0.942). The increased expression levels of miR-24, miR-33a, miR-103a, and miR-122 in PBMCs are associated with risk of CAD. A panel of the four miRNAs has considerable clinical value in diagnosing stable CAD.Keywords
This publication has 39 references indexed in Scilit:
- Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverJournal of Clinical Investigation, 2012
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesisJournal of Clinical Investigation, 2012
- Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patientsLipids in Health and Disease, 2012
- MicroRNAs in lipid metabolismCurrent Opinion in Lipidology, 2011
- Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*Journal of Biological Chemistry, 2010
- miR-33 links SREBP-2 induction to repression of sterol transportersProceedings of the National Academy of Sciences, 2010
- MiR-33 Contributes to the Regulation of Cholesterol HomeostasisScience, 2010
- Sirtuin gene expression in human mononuclear cells is modulated by caloric restrictionEuropean Journal of Clinical Investigation, 2008
- Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathwaysMolecular Genetics and Metabolism, 2007
- The evolution of gene regulation by transcription factors and microRNAsNature Reviews Genetics, 2007